Skip to content

Central Auditory Processing Disorders Associated With Blast Exposure

Central Auditory Processing Disorders Associated With Blast Exposure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00554801
Enrollment
84
Registered
2007-11-07
Start date
2007-10-31
Completion date
2011-12-31
Last updated
2018-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central Auditory Processing Disorder, Hearing Loss, Traumatic Brain Injury

Keywords

Central Auditory Processing, Traumatic Brain Injury, Hearing Loss

Brief summary

The incidence of central auditory dysfunction in war fighters who are exposed to high-explosive blasts while serving in combat have not been clearly determined. The objectives of this study are to determine whether central auditory processing (CAP) disorders are associated with exposure to high-explosive blasts. This study will also examine the incidence, magnitude and timing of spontaneous recovery of CAP function from blast exposure. The information provided by this study will help guide clinicians in both the military and VA health care systems regarding the likelihood of central auditory processing disorders in soldiers returning from deployment and suggest some clinical rehabilitative strategies for the treatment of these patients with CAP deficits.

Detailed description

The incidence and nature of central auditory dysfunction in combat soldiers who are exposed to high-explosive blasts have not been determined. Using a battery of behavioral and neurophysiological auditory tests, we propose to evaluate central auditory function in soldiers who recently have been exposed to explosive blasts while deployed in Iraq or Afghanistan. In collaboration with the Army Audiology & Speech Center at Walter Reed Army Medical Center (WRAMC), the research will be coordinated at the National Center for Rehabilitative Auditory Research (NCRAR) at the Portland VA Medical Center, and data collection will take place both at the NCRAR and at WRAMC. The study objectives are to determine if specific central auditory processing disorders are often associated with exposure to high-explosive blasts, and if these disorders spontaneously recover or remain over time. One hundred patients who have suffered a blast exposure, but have either no brain damage or mild traumatic brain injury (TBI), will be recruited at WRAMC to participate in this research study. A battery of central auditory processing tests will be administered to participants as soon as possible after their arrival at WRAMC. Patients who demonstrate aspects of central auditory processing disorder will be invited to participate in further testing nine to twelve months later. Those subjects will be brought to the NCRAR at the Portland VA Medical Center or will return to WRAMC for two days of auditory testing, where they will undergo the same battery of tests administered initially. Control subjects who do not have a history of blast exposure and who are matched in age, gender, and audiometric configuration with the experimental subjects will also be tested at the NCRAR site. Data extracted by interview and from medical records, including details of the blast exposure, scores on overall tests of brain function administered by the WRAMC TBI team, presence or absence of post traumatic stress disorder, as well as self-report questionnaires regarding quality of life, presence of tinnitus and/or balance problems, will be used in the interpretation of results.

Interventions

PROCEDUREAudiological testing

Subjects will take part in a battery of audiological tests meant to evaluate the function and status of the auditory system. These tests are similar to the kinds of testing carried out routinely in audiology clinics, and include behavioral tests of pure tone hearing, speech perception, and central auditory function, and electrophysiological testing of the middle ear and of the central auditory system.

Sponsors

Walter Reed Army Medical Center
CollaboratorFED
VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Experimental group: * Active duty soldier at Walter Reed Army Medical Center, Washington DC * a notation in medical record of exposure to blast * a Glasgow Coma Scale of 13-15, indicating mild or no traumatic brain injury (TBI * cognitive and physical ability to take part in these auditory evaluations. * Age 18 years or older * native speaker of English (since test materials are presented in English) Control group: * able to commute to Portland (Oregon)VA Med Ctr. * no exposure to blast * cognitive and physical ability to take part in these auditory evaluations. * age 18 years or older * native speaker of English

Exclusion criteria

* hearing loss greater than 50 dB HL three-frequency pure tone average bilaterally

Design outcomes

Primary

MeasureTime frameDescription
Audiological Test Resultsthree yearsAudiometric testing, with normal hearing specified as better (lower) than 25 decibels Hearing Level (dBHL), and a mild hearing loss between 25 to 50 dBHL.

Secondary

MeasureTime frameDescription
Quality of Life QuestionnaireThree yearsSelf-report questionnaires regarding quality of life

Countries

United States

Participant flow

Recruitment details

Active duty military who were exposed to a blast while deployed and were patients at Walter Reed Army Medical Center; only mild or no traumatic brain injury

Participants by arm

ArmCount
Blast-exposed
The study group includes soldiers who have recently been exposed to a high-explosive blast while stationed in Iraq or Afghanistan. They will be recruited at Walter Reed Army Medical Center, Washington, DC. Audiological testing: Subjects will take part in a battery of audiological tests meant to evaluate the function and status of the auditory system. These tests are similar to the kinds of testing carried out routinely in audiology clinics, and include behavioral tests of pure tone hearing, speech perception, and central auditory function, and electrophysiological testing of the middle ear and of the central auditory system.
36
Control Group
No exposure to high-intensity blast; matched to blast-exposed group on gender, age, and hearing loss
29
Total65

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall Studyleft area before completion50
Overall StudyWithdrawal by Subject140

Baseline characteristics

CharacteristicBlast-exposedControl GroupTotal
Age, Continuous32.8 years32.1 years32.5 years
Region of Enrollment
United States
36 participants29 participants65 participants
Sex: Female, Male
Female
4 Participants3 Participants7 Participants
Sex: Female, Male
Male
32 Participants26 Participants58 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 550 / 29
serious
Total, serious adverse events
0 / 550 / 29

Outcome results

Primary

Audiological Test Results

Audiometric testing, with normal hearing specified as better (lower) than 25 decibels Hearing Level (dBHL), and a mild hearing loss between 25 to 50 dBHL.

Time frame: three years

ArmMeasureValue (MEAN)Dispersion
Blast-exposedAudiological Test Results10.8 decibels Hearing LevelStandard Deviation 6
Control GroupAudiological Test Results6.6 decibels Hearing LevelStandard Deviation 4.2
Secondary

Quality of Life Questionnaire

Self-report questionnaires regarding quality of life

Time frame: Three years

Population: It was decided early during implementation of this study that the investigators would not collect self-report data on quality of life, so there are no data to report

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026